CVS Group (LON:CVSG) Releases Quarterly Earnings Results

CVS Group (LON:CVSG) released its quarterly earnings data on Thursday. The company reported GBX 85.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. CVS Group had a net margin of 2.31% and a return on equity of 5.35%.

Here are the key takeaways from CVS Group’s conference call:

• Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
• Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
• CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
• Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
• Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Price Performance

CVS Group stock traded down GBX 66.30 during midday trading on Thursday, reaching GBX 1,235.70. 419,617 shares of the company were exchanged, compared to its average volume of 880,155. The firm’s 50-day simple moving average is GBX 1,289.88 and its 200-day simple moving average is GBX 1,230. CVS Group has a 1 year low of GBX 1,062 and a 1 year high of GBX 1,648. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The company has a market capitalization of £839.91 million, a price-to-earnings ratio of 17.93, a P/E/G ratio of 1.77 and a beta of 1.07.

Insiders Place Their Bets

In other CVS Group news, insider Joanne Shaw bought 1,592 shares of the stock in a transaction dated Monday, August 10th. The stock was bought at an average cost of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider Robin Alfonso purchased 768 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The stock was bought at an average cost of GBX 1,294 per share, for a total transaction of £9,937.92. Insiders have purchased a total of 3,860 shares of company stock worth $4,956,696 over the last quarter. 1.48% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research report on Thursday. Shore Capital Group restated a “hold” rating and issued a GBX 1,400 price target on shares of CVS Group in a research note on Thursday. Jefferies Financial Group increased their target price on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a report on Monday, July 27th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.